UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
Amendment No. 3
|
| |
[X] | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
|
| For the Fiscal Year EndedJune 30, 2010 |
|
|
|
|
x | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT |
|
For the transition period from ________ to ______
FERO INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Colorado | 000-53337 | 01-0884561 |
(State or other jurisdiction | (Commission File Number) | (IRS Employer |
of Incorporation) |
| Identification Number) |
| 254-16 Midlake Boulevard SE Calgary Alberta, Canada T2X 2X7 (Address of principal executive offices) |
|
| (403) 827-7936 |
|
| (Registrant’s Telephone Number) |
|
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to section 12(g) of the Act:
Common Stock, $0.001 par value
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☐
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K/A or any amendment to this Form 10-K. Yes ☐ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
☐
Accelerated Filer
☐
Non-Accelerated Filer
☐
Smaller Reporting Company
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☐
|
|
|
|
|
|
|
|
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently computed second fiscal quarter: $6,380,000.
The number of shares of the issuer’s common stock issued and outstanding as of June 30, 2010 was 127,500,000 shares.
Documents Incorporated By Reference: None
Item 8. Financial Statements and Supplementary Data.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and
Stockholders of Fero Industries Inc.
(a Development Stage Company)
We have audited the accompanying balance sheets of Fero Industries Inc. (a Development Stage Company) (the Company) as of June 30, 2010 and 2009, and the related statements of operations, stockholders’ equity, and cash flows for each of the years in the two-year period ended June 30, 2010 and for the period from the date of inception (December 11, 2000) to June 30, 2010. The Company’s management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significan t estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Fero Industries Inc. (a Development Stage Company) as of June 30, 2010 and 2009, and the results of its operations and its cash flows for each of the years in the two-year period ended June 30, 2010 and for the period from date of inception (December 11, 2000) to June 30, 2010 in conformity with accounting principles generally accepted in the United States of America.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company does not have the necessary working capital to service its debt and for its planned activity, which raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are described in the notes to the financial statements. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Madsen & Associates CPA’s, Inc. Murray, Utah December 13, 2010 | |
|
|
FERO INDUSTRIES INC.
(A Development Stage Company)
Balance Sheets
| June 30, |
| June 30, |
| 2010 |
| 2009 |
ASSETS |
|
|
|
|
|
|
|
Current Assets: |
|
|
|
Cash | $ - |
| $ - |
Total Current Assets | $ - |
| $ - |
|
|
|
|
Total Assets | $ - |
| $ - |
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
|
|
|
|
|
|
|
Current Liabilities: |
|
|
|
Accounts payable | $ 6,150 |
| $ 10,250 |
Total Current Liabilities | 6,150 |
| 10,250 |
|
|
|
|
Advances from shareholder | 36,255 |
| 12,500 |
Promissory note payable | 250,000 |
| - |
Total liabilties | 292,405 |
| 22,750 |
|
|
|
|
Stockholders' Equity (Deficit): |
|
|
|
Preferred stock, $.001 par value; authorized 10,000,000, none issued | - |
| - |
Common stock, $.001 par value; 500,000,000 shares authorized |
|
|
|
127,500,000 shares issued and outstanding at |
|
|
|
June 30, 2010 and June 30, 2009 | 127,500 |
| 127,500 |
Additional paid in capital | (90,900) |
| (90,900) |
Accumulated deficit | (329,005) |
| (59,350) |
|
|
|
|
Total Stockholders' Equity (Deficit) | (292,405) |
| (22,750) |
|
|
|
|
Total Liabilities and Stockholders' Equity (Deficit) | $ - |
| $ - |
|
|
|
|
F3
FERO INDUSTRIES INC.
(A Development Stage Company)
Statement of Operations
|
|
| From |
|
|
| December 11, |
| (Restated) | (Restated) | 2000 |
| For the | For the | (Date of |
| year | year | inception) |
| ended | ended | to |
| June 30, | June 30, | June 30, |
| 2010 | 2009 | 2010 |
|
|
|
|
Revenue: | $ - | $ - | $ - |
Total Revenue | - | - | - |
|
|
|
|
Operating Expenses: |
|
|
|
General & administrative | 19,655 | 13,150 | 79,005 |
Impairment of bioceutical assets | 250,000 |
| 250,000 |
Total Operating Expenses | 269,655 | 13,150 | 329,005 |
|
|
|
|
NET LOSS | $ (269,655) | $ (13,150) | $ (329,005) |
|
|
|
|
Weighted Average Shares |
|
|
|
Common Stock Outstanding | 127,500,000 | 127,500,000 |
|
|
|
|
|
Net Loss Per Share |
|
|
|
(Basic and Fully Dilutive) | $ - | $ - |
|
|
|
|
|
F4
FERO INDUSTRIES INC.
(A Development Stage Company
Statement of Shareholders Equity
|
| Preferred | Stock | Common | Stock |
|
| (Deficit) |
|
|
|
|
|
|
| Additional | Stock | accumulated |
|
|
| Shares | Par Value | Share | Par Value | Paid-In | Subscription | in development |
|
|
| Issued | $.001 per | Issued | $.001 per | Capital | Receivable | stage | Total |
|
|
|
|
|
|
|
|
|
|
BALANCE- December 11, 2000 (inception) | - | $ - | - | $ - | $ - | $ - | $ - | $ - | |
| Issuance of common stock in exchange December 11, 2000 |
|
| 15,000,000 | 15,000 | $ (14,400) |
|
| 600 |
| Net (loss) |
|
|
|
|
|
| (600) | (600) |
BALANCE- June 30, 2006 | - | - | 15,000,000 | 15,000 | 14,400) | - | (600) | - | |
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock in exchange for services – December 28, 2006 |
|
| 12,500,000 | 12,500 | $ (12,000) |
|
| 500 |
| Issuance of common stock for domain names at $.01 per share – April 20, 2007 |
|
| 12,500,000 | 12,500 | $ (12,000) |
|
| 500 |
| Issuance of common stock for cash at April 30, 2007 |
|
| 77,500,000 | 77,500 | $ (46,500) |
|
| 31,000 |
| Issuance of common stock And subscriptions receivable at $0.01 per share – May 10, 2007 |
|
| 10,000,000 | 10,000 | $ (6,000) | (4,000) |
| - |
| Receipt of subscription receivable |
|
|
|
|
| 4,000 |
| 4,000 |
| Net (loss) |
|
|
|
|
|
| (11,500) | (11,500) |
BALANCE- June 30, 2007 | - | - | 127,500,000 | 127,500 | (90,900) | - | (12,100) | 24,500 | |
|
|
|
|
|
|
|
|
|
|
| Net (loss) |
|
|
|
|
|
| (34,100) | (34,100) |
BALANCE- June 30, 2008 | - | - | 127,500,000 | 127,500 | (90,900) | - | (46,200) | (9,600) | |
|
|
|
|
|
|
|
|
|
|
| Net (loss) |
|
|
|
|
|
| (13,150) | (13,150) |
BALANCE- June 30, 2009 | - | - | 127,500,000 | 127,500 | (90,900) | - | (59,350) | (22,750) | |
|
|
|
|
|
|
|
|
|
|
| Stock dividend: April 20, 2010; 4 for 1 |
|
|
|
|
|
|
|
|
| Net (loss) |
|
|
|
|
|
| (269,655) | (269,655) |
BALANCE- June 30, 2010 | - | - | 127,500,000 | 127,500 | (90,900) | - | (329,005) | (292,405) | |
|
|
|
|
|
|
|
|
|
|
F5
FERO INDUSTRIES INC.
(A Development Stage Company)
Statement of Cash Flows
|
|
| From |
|
|
| December 11, |
|
|
| 2000 |
| For the | For the | (Date of |
| year | year | inception) |
| ended | ended | to |
| June 30, | June 30, | June 30, |
| 2010 | 2009 | 2010 |
Cash Flows Used in Operating Activities: |
|
|
|
Net Loss | $ (269,655) | $ (13,150) | $ (329,005) |
Adjustments to reconcile net (loss) to net cash |
|
|
|
provided by operating activites: |
|
|
|
Impairment of bioceutical assets | 250,000 |
| 250,000 |
Issuance of stock for services rendered | - | - | 1,600 |
Increase in accounts payable | (4,100) | 10,250 | 6,150 |
| - | - | - |
|
|
|
|
|
|
|
|
Net Cash Used in Operating Activities | (23,755) | (2,900) | (71,255) |
|
|
|
|
Cash Flows from Investing Activities: | - | - | - |
|
|
|
|
Cash Flows from Financing Activities: |
|
|
|
Issuance of common stock for cash | - | - | 35,000 |
Loan from shareholder | 23,755 | 2,500 | 36,255 |
|
|
|
|
Net Cash Provided by Financing Activities | 23,755 | 2,500 | 71,255 |
|
|
|
|
Net Increase (Decrease) in Cash | - | (400) | - |
|
|
|
|
Cash at Beginning of Year | - | 400 | - |
|
|
|
|
Cash at End of Year | $ - | $ - | $ - |
|
|
|
|
Non-Cash Investing & Financing Activities |
|
|
|
Issuance of stock for management services rendered | $ - | $ - | $ 1,600 |
Acquisition of bioceutical assets for promisorry note | 250,000 |
| 250,000 |
|
|
|
|
F6
FERO INDUSTRIES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(RESTATED)
NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION
NATURE OF OPERATIONS
Fero Industries, Inc. (the “Company”) was incorporated under the laws of the State of Colorado on December 11, 2000. The Company’s activities to date have been limited to organization and capital formation. The Company is a “development stage company”
BASIS OF PRESENTATION
These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in US dollars.
NOTE 2 – NATURE OF SIGNIFICANT ACCOUNTING POLICIES
CASH AND CASH EQUIVALENTS
The Company considers all highly liquid debt instruments purchased with maturity of three months or less to be cash equivalents.
REVENUE RECOGNITION
The Company recognizes revenue at the time services are performed.
USE OF ESTIMATES
The preparation of the Company’s financial statements requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.
FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company’s short-term financial instruments consist of cash and cash equivalents and accounts payable. The carrying amounts of these financial instruments approximate fair value because of their short-term maturities. The Company does not hold or issue financial instruments for trading purposes nor does it hold or issue interest rate or leveraged derivative financial instruments.
EARNINGS PER SHARE
Basic Earnings per Share (“EPS”) is computed by dividing net income available to common stockholders by the weighted average number of common stock shares outstanding during the year. Diluted EPS is computed by dividing net income available to common stockholders by the weighted-average number of common stock shares outstanding during the year plus potential dilutive instruments such as stock options and warrants. Basic and diluted EPS are the same for the Company, as of June 30, 2010, as the Company does not have any common share equivalents outstanding.
F7
FERO INDUSTRIES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(RESTATED)
FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company’s short-term financial instruments consist of cash and cash equivalents and accounts payable. The carrying amounts of these financial instruments approximate fair value because of their short-term maturities. The Company does not hold or issue financial instruments for trading purposes nor does it hold or issue interest rate or leveraged derivative financial instruments.
EARNINGS PER SHARE
Basic Earnings per Share (“EPS”) is computed by dividing net income available to common stockholders by the weighted average number of common stock shares outstanding during the year. Diluted EPS is computed by dividing net income available to common stockholders by the weighted-average number of common stock shares outstanding during the year plus potential dilutive instruments such as stock options and warrants. Basic and diluted EPS are the same for the Company, as of June 30, 2010, as the Company does not have any common share equivalents outstanding.
INCOME TAXES
The Company uses the asset and liability method of accounting for income taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of certain assets and liabilities. Deferred income tax assets and liabilities are computed annually for the difference between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period, plus or minus the change during the period in deferred tax assets and liabilities.
Deferred income taxes may arise from temporary differences resulting from income and expanse items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of the assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. As of June 30, 2010, the Company has recorded a valuation allowance to fully offset the deferred tax asset of approximately $112,000 related to its cumulative net operating losses of $329,005.
CONCENTRATION OF CREDIT RISK
Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash. During the year the Company did not maintain cash deposits at financial institution in excess of the $100,000 limit covered by the Federal Deposit Insurance Corporation.
F8
FERO INDUSTRIES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(RESTATED)
RECENT ACCOUNTING PRONOUNCEMENTS
The Company does not expect that the adoption of recent accounting pronouncements will have a material impact on its financial statements.
NOTE 3 – ACQUISITION OF DOMAIN NAMES AND DEPOSITS
On April 20, 2007, the Company entered into an asset purchase and sale agreement with Mr. Jerry Capehart of Grand Prairie, Texas whereby he sold to us a 100% undivided right title and interest in seventeen internet domain names for a total purchase price of $180,000. Terms of the purchase are as follows: $5,000 to Mr. Capehart and 2,500,000 shares of our common stock as a non-refundable deposit (recorded as Deposits on the Balance Sheet) and an additional $75,000 on or before June 30, 2008. All domain names are fully valid and registered and ready for construction. The Company did not fulfill its duties in the contract. As such, the Company has not recorded the liability or corresponding asset related to this sale agreement in its financial statements.
NOTE 4– ACQUISITION OF SUCANON
On May 23, 2010, Fero Industries, Inc., a Colorado corporation, (the "Company") entered that certain Asset Acquisition Agreement (the "Agreement") with Gvest, Inc., (“Gvest”) an Ontario, Canada corporation. Pursuant to the terms and conditions of the Agreement, the Company acquired certain assets directly related to the manufacturing, sale and distribution of that certain product known as Sucanon, which is an herbal remedy for Type II Diabetes. The acquired assets include all of the intellectual property rights, training, and “know how” to manufacture and produce Sucanon, including sources and suppliers of Sucanon ingredients and mixing equipment; certain associated trademarks and patents ("Acquired Assets"). The Acquired Assets include the exclusive world-wide rights to manufacture, sell and distribute Sucanon. The Company purchased the Acquired Assets for an aggregate purchase price of $250,000. The Agreement contai ned customary representations and warranties and pre- and post-closing covenants of each party and customary closing conditions. Breaches of the representations and warranties were subject to customary indemnification provisions, subject to specified aggregate limits of liability. As of June 30, 2010 this transaction was not closed.
NOTE 5 – COMMON STOCK
On December 11, 2000 the Company issued 15,000,000 shares of its common stock to its President and Chief Executive Officer, Kyle Schlosser for $600 in return for his time effort and expense of forming the company and keeping it in good standing.
On December 28, 2006 the Company issued 12,500,000 shares of our common stock to our Secretary/Treasurer and Chief Financial Officer, Leigh-Ann Squire for $500 in return for her agreement to join our Board of Directors, become an officer of the registrant and his agreement to provide the computer and internet expertise in constructing our websites and providing the server for operation of the sites, at no charge.
F9
FERO INDUSTRIES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(RESTATED)
As referred to in Note 4 above, on April 20, 2007 the Company issued 12,500,000 shares of our common stock to Mr. Jerry Capehart of Grand Prairie, Texas for $500, as a good faith deposit for seventeen domain names relating to the oil and gas industry.
On April 30, 2007 the Company issued 77,500,000 shares of our common stock to thirty-one non US persons for cash of $31,000.
On May 10, 2007 the Company issued 10,000,000 shares of our common stock to three US individuals (one representing a Grandchildren’s Trust), for cash of $4,000.
On November 18, 2008 the Board of Directors of the registrant passed unanimously a resolution authorizing a forward split of the authorized and issued and outstanding common shares on a three to one (5 – 1) basis bringing the total common shares issued and outstanding to 25,500,000. The forward split has been retroactively recorded in the financial statements of the Company as if the forward split had occurred at the inception of the Company and the authorized common shares have increased to 500,000,000.
On April 15, 2010 the Board of Directors of Fero Industries (the Registrant) passed a resolution declaring a stock dividend of four (4) shares of common stock for each share held, of record as of April 20, 2010. The common shares of the Registrant will be considered Ex Dividend on April 21, 2010. This brings the total issued and outstanding common shares to 127,500,000. All share references in these financial statements have been retroactively adjusted for this stock dividend.
NOTE 6- PROMISSORY NOTE
On June 24, 2010, we issued a Two Hundred Fifty Thousand Dollars ($250,000) Promissory Note (the “Note”) in favor of Mr. Peter Hogendoorn (the “Lender”). The Note contains standard representations, and warranties and affirmative and negative covenants, and is described in greater detail below. The Note memorializes a loan made by the Lender to the Company, in order for the Company to close that certain Asset Acquisition Agreement with Gvest. The Note accrues simple interest at a rate equal to 1% over the average Canadian Prime Rate and is due 30 days from the date executed, or thereafter by mutual agreement of the parties hereto, the principal and all accrued interest thereon shall be due and payable within ten (10) days of written demand by Holder. Additionally, the Note may be repaid in whole or in part by the Company without penalty or premium at any time and from time to time prior to the Maturity Date.
NOTE 7– GOING CONCERN
The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has no sales and has incurred a net loss of $329,005 since inception. The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the development of its mineral properties. Management has plans to seek additional capital through a private placement and public offering of its common stock. The financial statements do not include any adjustments relating to the recoverability and classifications of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.
F10
FERO INDUSTRIES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(RESTATED)
NOTE 8- RESTATEMENT
The Company is restating its June 30, 2010 balance sheet to reclassify the Advances from shareholder and Promissory note payable from long term to current liabilities. The Company is restating its statements of operations to reflect the correct number of weighted average number of shares outstanding, which previously did not give retroactive effect to the April 1, 2010 stock dividend. The Company is restating its statement of stockholders’ equity to disclose the correct net loss for the year ended June 30, 2010. The Company is also adjusting its statement of stockholders’ equity to correctly present the stock dividend that occurred on April 15, 2010 (retroactive adjustment). These adjustments had no effect on the results of operations.
The Company is also restating its footnotes to add a subsequent events footnote for the Asset Acquisition Agreement that closed on July 7, 2010.
NOTE 9- SUBSEQUENT EVENTS (RESTATED)
On July 7, 2010, the Company closed its Asset Acquisition Agreement that will allow the Company to move forward with its new business plan to make, manufacture, and distribute Sucanon world-wide. The acquired assets include:
·
Intellectual property rights, training, and “know how” to manufacture and produce Sucanon
·
Sources and suppliers of Sucanon ingredients and mixing equipment
·
Certain associated trademarks and patents ("Acquired Assets")
·
Inventory
·
World-wide rights to manufacture, sell and distribute Sucanon
·
75% ownership of Smith Rothe Pharmaceutical (“Smith Rothe”)
·
98% ownership of Pharmaroth SA de CV, a Mexican corporation (“Pharmaroth”)
·
100% of 314202 B.C. Ltd., a Canadian corporation
The purchase price of these assets was $250,000. The Company performed a subsequent impairment test on the acquired assets and determined that there was an impairment. Therefore, the Company decided to report an impairment loss of $250,000 as of June 30, 2010. Also, since the acquired companies had no significant operations, assets, or liabilities, no pro-forma information is presented.
On September 22, 2010 and October 1, 2010 the Company issued a total of 5,850,000 shares of its common stock at $.04 per share for legal and consulting services.
The Company has evaluated subsequent events through December 13, 2010.
Item 9A. Controls and Procedures.
Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2010. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of June 30, 2010 using the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of June 30, 2010, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.
1.
As of June 30, 2010, effective controls over the control environment were not maintained. Specifically, a formally adopted written code of business conduct and ethics that governs the Company’s employees, officers and directors was not in place. Additionally, management has not developed and effectively communicated to its employees its accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-B. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.
2.
As of June 30, 2010, effective controls over financial statement disclosure were not maintained. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.
3.
As of June 30, 2010, effective controls over equity transactions were not designed or in place. Specifically, controls were not designed to ensure that equity transactions were properly reflected. Accordingly, management has determined that this control deficiency constitutes a material weakness.
4.
As of June 30, 2010, our current disclosure controls and procedures were not effective to ensure that we record, process, summarize, and report the information we must disclose in reports that we file or submit under the Exchange Act, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate to allow timely discussions regarding required disclosures.
Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.
As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of June 30, 2010 based on criteria established in Internal Control—Integrated Framework issued by COSO.
Our independent registered public accounting firm was not required to, and has not, issued a report concerning the effectiveness of our internal control over financial reporting as of June 30, 2010.
Continuing Remediation Efforts to address deficiencies in Company’s Internal Control over Financial Reporting
Our management and Board of Directors plan to establish the following remediation measures during the fiscal year ended June 30, 2010:
·
Our Board of Directors will nominate an audit committee and audit committee financial expert to ensure that we establish appropriate internal controls over our financial reporting process, including formal review and approval of our financial statements and the review, implementation, and monitoring of necessary internal controls, procedures, and policies to mitigate the potential risk of material misstatement of our financial records.
Changes in Internal Controls.
There were no changes in our internal control over financial reporting,
identified in connection with the evaluation of such internal control that occurred during our fiscal quarter ended June 30, 2010 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
ITEM 15. EXHIBITS
|
|
|
31.1 | Rule 13a-14(a)/15d-14(a) Certifications of Chief Executive Officer | Filed herewith. |
31.2 | Rule 13a-14(a)/15d-14(a) Certifications of Chief Financial Officer | Filed herewith. |
32.1 | Section 906 Certifications by Chief Executive Officer | Filed herewith. |
32.2 | Section 906 Certifications by Chief Financial Officer | Filed herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
| Fero Industries, Inc. |
| |
|
|
|
|
| /s/ Kyle Schlosser |
| |
| By: Its: | Kyle Schlosser Chief Executive Officer, President & Director |
|
In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.
|
|
|
| |
/s/ Kyle Schlosser |
| February 18, 2011 | ||
By: | Kyle Schlosser |
|
| |
Its: | Chief Executive Officer, President & Director |
| ||
|
|
|
| |
/s/ Leigh-Ann Squire |
| February 18, 2011 | ||
By: | Leigh-Ann Squire |
|
| |
Its: | Principal Financial Officer, Treasurer, Secretary and Director |
| ||
